Wikipedia -WSS

Wikipedia

author：fashion 2025-09-06 03:58:01 - browse：15

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： EU regulator recommends expanding Mounjaro approval to obesity

knowledge

WSS

Elizabeth Holmes banned from government health programs

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Medicare Advantage today, explained in one chart

Eli Lilly, Pfizer, and others want in on the online prescription market

Elizabeth Holmes banned from government health programs

How generative AI is inspiring dreams of a health data revolution

leisure time

Wikipedia

focus

Walensky prepares to leave CDC — and Congress — behind

Humana cuts profit projections as Medicare Advantage costs soar

Medicare details structure of new drug price negotiation program

Medicare Advantage today, explained in one chart

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

As demand for Covid shots wanes, Moderna seeks its next success

'Make People Better': The CRISPR babies story you probably don't know

Trump demands the U.S. pay no more for drugs than other countries … again

Trump surgeon general acknowledges mistakes during Covid

Wikipedia

Elizabeth Holmes banned from government health programs

Stem cell treatment guidelines are released by FDA

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Advances in CAR

Why Novartis is changing the name of its research labs

Francis Collins on trust in science and how Covid communications failed

knowledge

knowledge

explore

focus